<DOC>
	<DOCNO>NCT01956526</DOCNO>
	<brief_summary>The study purpose evaluate safety feasibility CORolla™ TAA two treatment group , `` CORolla™ Stand-alone group '' `` AVR &amp; CORolla™ Add group '' .</brief_summary>
	<brief_title>CORolla™ TAA Heart Failure Preserved Ejection Fraction Diastolic Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<criteria>Clinical criterion Adult ( age &gt; 18 year ) Diagnosis heart failure preserve systolic function accord ESC 2008 Guidelines ( ejection fraction ≥ 50 % ) NYHA F. Class III IV symptom history previous heart failure hospitalization last year Able sign inform consent return followup visit . No contraindication anticoagualation antiplatelet treatment . Cardiac medication unchanged great 4 week ( include diuretic ) Pulmonary Wedge pressure &gt; 15 mmHg document right heart catheterization enrollment . Echocardiographic criterion Preserved regional wall motion ( wall motion abnormality ) . Left ventricular ejection fraction ≥ 50 % LV enddiastolic volume index ( LVEDVI ) &lt; 97 ml/m2 . Left Atrial Volume Index : ( LAVi &gt; 29 ml/m2 ) . E/E ' ratio ( mean septal lateral ) ≥12 ( applicable patient sinus rhythm ) No intracardiac thrombus . Minimal endocardial height Apex Mitral Annulus ≥ 70mm . Cardiovascular disease Uncontrolled HTN define &gt; 140/90 mmHg , &gt; 160/90 mmHg patient 3drug therapy Current anticipate need ICD , currently implant cardiac resynchronization device ( CRT ) , leave ventricular assist device ( LVAD ) . Within past 3 month Acute myocardial infarction ( AMI ) , cerebral vascular accident ( CVA ) , Transient Ischemic Attack ( TIA ) , Percutaneous coronary intervention ( PCI transmyocardial laser revascularization ( TMR PMR ) Valvular disease ( unless add aortic valve replacement due aortic stenosis ) Hypertrophic cardiomiopathy Pericardial disease Cor pulmonale cause isolate right heart failure . Non reversible pulmonary hypertension . Right ventricle failure right ventricular myocardial infarction . Infiltrative heart disease Noncardiovascular disease Noncardiovascular condition limit ability assess 6minute hall walk test Prior surgery , radiation , thoracic surgery limit ability place device Body mass index great 40 Uncontrolled hyperglycemic status address HbA1c &gt; 8.5 % Asthma COPD ( e.g . FEV1 &lt; 1.5 liter ) , severe restrictive lung disease Severe chronic renal failure indicate MDRD GFR &lt; 30 mL/min/1.73 m2 Liver impairment address bilirubin &gt; 2 mg/dl pseudo colinesterasis plasma concentration &lt; 1500 IU and/or abnormal coagulative profile Severe anemia address Hb concentration &lt; 10 gr/l . Solid organ hematologic transplant . Previous Trans Apical procedures/implantation Miscellaneous condition Unwilling fulfill protocol medication compliance , test , followup requirement Comorbid condition physician 's opinion would prohibit subject 's ability meet protocol requirement Pregnancy time enrollment . ( Women child bear potential must negative serum pregnancy test within two week prior enrollment , use hormonal contraceptive intrauterine device ) Enrolled another investigational study A history alcohol abuse , drug addiction , psychosocial condition would preclude successful participation , clear judgment inform consent opinion Principal Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Heart Failure Preserved Ejection Fraction ( HFpEF )</keyword>
	<keyword>Diastolic Heart Failure ( DHF )</keyword>
	<keyword>Diastolic Dysfunction ( DD )</keyword>
</DOC>